Form 8-K - Current report:
SEC Accession No. 0000950170-25-047196
Filing Date
2025-03-31
Accepted
2025-03-31 07:03:52
Documents
13
Period of Report
2025-03-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K caba-20250331.htm   iXBRL 8-K 47386
2 EX-99.1 caba-ex99_1.htm EX-99.1 121760
3 GRAPHIC img132663336_0.jpg GRAPHIC 6003
  Complete submission text file 0000950170-25-047196.txt   308004

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT caba-20250331.xsd EX-101.SCH 26027
15 EXTRACTED XBRL INSTANCE DOCUMENT caba-20250331_htm.xml XML 4937
Mailing Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104
Business Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104 (267) 759-3100
Cabaletta Bio, Inc. (Filer) CIK: 0001759138 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39103 | Film No.: 25788810
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)